Product
CBT-006
1 clinical trial
1 indication
Indication
Meibomian Gland DysfunctionClinical trial
A Phase 2 Multicenter, Double-masked, Randomized, Vehicle-controlled, Parallel Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland DysfunctionStatus: Completed, Estimated PCD: 2023-08-17